Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection

Frontiers in Cellular and Infection Microbiology - Switzerland
doi 10.3389/fcimb.2017.00472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Recombinant Human Interleukin 2 Treatment in Patients With Chronic Hepatitis B Virus Infection.

Japanese Journal of Clinical Immunology
1989English

Soluble Immune Markers in the Different Phases of Chronic Hepatitis B Virus Infection

Scientific Reports
Multidisciplinary
2019English

Effects of Antiviral Therapy on the Cellular Immune Response in Patients With Chronic Hepatitis B

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2010English

Innate Immune Responses in Hepatitis B Virus (HBV) Infection

Virology Journal
VirologyInfectious Diseases
2014English

Antiviral Β-L-Nucleosides Specific for Hepatitis B Virus Infection

2003English

Interleukin-6 Haplotypes and the Response to Therapy of Chronic Hepatitis C Virus Infection

Genes and Immunity
ImmunologyGenetics
2009English

Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy